IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 11 3 2020
medline: 15 4 2021
entrez: 11 3 2020
Statut: ppublish

Résumé

One-anastomosis gastric bypass (OAGB-MGB) is currently the third performed primary bariatric surgical procedure worldwide. However, the procedure is hampered by numerous controversies and there is considerable variability in surgical technique, patient selection, and pre- and postoperative care among the surgeons performing this procedure. This paper reports the results of a modified Delphi consensus study organized by the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO). Fifty-two internationally recognized bariatric experts from 28 countries convened for voting on 90 consensus statements over two rounds to identify those on which consensus could be reached. Inter-voter agreement of ≥ 70% was considered consensus, with voting participation ≥ 80% considered a robust vote. At least 70% consensus was achieved for 65 of the 90 questions (72.2% of the items), 61 during the first round of voting and an additional four in the second round. Where consensus was reached on a binary agree/disagree or yes/no item, there was agreement with the statement presented in 53 of 56 instances (94.6%). Where consensus was reached on a statement where options favorable versus unfavorable to OAGB-MGB were provided, including statements in which OAGB-MGB was compared to another procedure, the response option favorable to OAGB-MGB was selected in 13 of 23 instances (56.5%). Although there is general agreement that the OAGB-MGB is an effective and usually safe option for the management of patients with obesity or severe obesity, numerous areas of non-consensus remain in its use. Further empirical data are needed.

Sections du résumé

BACKGROUND BACKGROUND
One-anastomosis gastric bypass (OAGB-MGB) is currently the third performed primary bariatric surgical procedure worldwide. However, the procedure is hampered by numerous controversies and there is considerable variability in surgical technique, patient selection, and pre- and postoperative care among the surgeons performing this procedure. This paper reports the results of a modified Delphi consensus study organized by the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO).
METHODS METHODS
Fifty-two internationally recognized bariatric experts from 28 countries convened for voting on 90 consensus statements over two rounds to identify those on which consensus could be reached. Inter-voter agreement of ≥ 70% was considered consensus, with voting participation ≥ 80% considered a robust vote.
RESULTS RESULTS
At least 70% consensus was achieved for 65 of the 90 questions (72.2% of the items), 61 during the first round of voting and an additional four in the second round. Where consensus was reached on a binary agree/disagree or yes/no item, there was agreement with the statement presented in 53 of 56 instances (94.6%). Where consensus was reached on a statement where options favorable versus unfavorable to OAGB-MGB were provided, including statements in which OAGB-MGB was compared to another procedure, the response option favorable to OAGB-MGB was selected in 13 of 23 instances (56.5%).
CONCLUSION CONCLUSIONS
Although there is general agreement that the OAGB-MGB is an effective and usually safe option for the management of patients with obesity or severe obesity, numerous areas of non-consensus remain in its use. Further empirical data are needed.

Identifiants

pubmed: 32152841
doi: 10.1007/s11695-020-04519-y
pii: 10.1007/s11695-020-04519-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1625-1634

Investigateurs

Mohamed Abou Zeid (MA)
Salman Al Sabah (S)
Priscila Antozzi (P)
Moataz Bashah (M)
Ahmad Bashir (A)
Estuardo Behrens (E)
Mohit Bhandari (M)
Aurelio Bottino (A)
Miguel Carbajo (M)
Leonardo Emilio da Silva (LE)
Maurizio De Luca (M)
Eric DeMaria (E)
Mohamad Hayssam ElFawal (MH)
Mathias A L Fobi (MAL)
Mohammed Khalid Mirza Gari (MKM)
David E Hargroder (DE)
Glenda Herrera (G)
Kelvin Higa (K)
Jacques Himpens (J)
Gurvinder Singh Jammu (GS)
Ali Khammas (A)
Kuldeepak Singh Kular (KS)
Muffazal Lakdawala (M)
Laurent Layani (L)
Enrique Luque-de-León (E)
Mario Musella (M)
Francisco Pacheco (F)
Chetan Parmar (C)
Cesare Peraglie (C)
Gerhard Prager (G)
Arun Prasad (A)
Karl P Rheinwalt (KP)
Rui Ribeiro (R)
Maud Robert (M)
Raul Rosenthal (R)
Bassem Safadi (B)
Nasser Sakran (N)
Asim Shabbir (A)
Peter K Small (PK)
Michel Suter (M)
Osama Taha (O)
Craig Taylor (C)
Sergio Verboonen (S)
Cunchuan Wang (C)
Rudolf Weiner (R)
Nick Williams (N)

Références

Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:5.
Carbajo MA, Garcia-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;5:7.
De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28(5):1188–206.
pubmed: 29600339 pmcid: 29600339 doi: 10.1007/s11695-018-3182-3
Alkhalifah N, Lee WJ, Hai TC, et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018;32(7):3024–31.
pubmed: 29313123 pmcid: 29313123 doi: 10.1007/s00464-017-6011-1
Carbajo MA, Luque-de-Leon E, Jimenez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.
pubmed: 27783366 pmcid: 27783366 doi: 10.1007/s11695-016-2428-1
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8.
pubmed: 25585612 pmcid: 25585612 doi: 10.1007/s11695-014-1552-z
Lessing Y, Pencovich N, Khatib M, et al. One-anastomosis gastric bypass: first 407 patients in 1 year. Obes Surg. 2017;27(10):2583–9.
pubmed: 28391439 pmcid: 28391439 doi: 10.1007/s11695-017-2668-8
Mahawar KK, Jennings N, Brown J, et al. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013;23(11):1890–8.
pubmed: 23934271 pmcid: 23934271 doi: 10.1007/s11695-013-1026-8
Parmar CD, Mahawar KK. One anastomosis (mini) gastric bypass is now an established bariatric procedure: a systematic review of 12,807 patients. Obes Surg. 2018;28(9):2956–67.
pubmed: 29995293 pmcid: 29995293 doi: 10.1007/s11695-018-3382-x
Parmar CD, Mahawar KK, Boyle M, et al. Mini gastric bypass: first report of 125 consecutive cases from United Kingdom. Clin Obes. 2016;6(1):61–7.
pubmed: 26781603 pmcid: 26781603 doi: 10.1111/cob.12124
Abdel-Rahim MM, Magdy MM, Mohamad AA. Comparative study between effect of sleeve gastrectomy and mini-gastric bypass on type 2 diabetes mellitus. Diabetes Metab Syndr. 2018;12(6):949–54.
pubmed: 29910066 pmcid: 29910066 doi: 10.1016/j.dsx.2018.06.001
Almalki OM, Lee WJ, Chong K, et al. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14(4):509–15.
pubmed: 29555031 pmcid: 29555031 doi: 10.1016/j.soard.2017.12.022
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24(10):1724–8.
pubmed: 24805912 pmcid: 24805912 doi: 10.1007/s11695-014-1264-4
Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24(9):1552–62.
pubmed: 24965545 pmcid: 24965545 doi: 10.1007/s11695-014-1344-5
Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. One-anastomosis gastric bypass versus sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2479–87.
pubmed: 28681256 pmcid: 28681256 doi: 10.1007/s11695-017-2807-2
Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8(3):159–69.
pubmed: 29573175 pmcid: 29573175 doi: 10.1111/cob.12246
Parmar C, Abdelhalim MA, Mahawar KK, et al. Management of super-super obese patients: comparison between one anastomosis (mini) gastric bypass and Roux-en-Y gastric bypass. Surg Endosc. 2017;31(9):3504–9.
doi: 10.1007/s00464-016-5376-x pubmed: 27981383
Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.
doi: 10.1016/S0140-6736(19)30475-1 pubmed: 30851879
Mahawar KK, Kular KS, Parmar C, et al. Perioperative practices concerning one anastomosis (mini) gastric bypass: a survey of 210 surgeons. Obes Surg. 2018;28(1):204–11.
pubmed: 28735375 pmcid: 28735375 doi: 10.1007/s11695-017-2831-2
Mahawar KK, Himpens J, Shikora SA, et al. The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg. 2018;28(2):303–12.
pubmed: 29243145 pmcid: 29243145 doi: 10.1007/s11695-017-3070-2
Keeney S, Hasson FHM. The Delphi technique in nursing and health research. Wiley-Blackwell: Chichester; 2011.
doi: 10.1002/9781444392029
Abu-Abeid A, Lessing Y, Pencovich N, et al. Diabetes resolution after one anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14(2):181–5.
pubmed: 29198751 pmcid: 29198751 doi: 10.1016/j.soard.2017.10.023
Carbajo MA, Jimenez JM, Castro MJ, et al. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass. Nutr Hosp. 2014;30(5):1032–8.
pubmed: 25365005 pmcid: 25365005
Hussain A, El-Hasani S. Short- and mid-term outcomes of 527 one anastomosis gastric bypass/mini-gastric bypass (OAGB/MGB) operations: retrospective study. Obes Surg. 2019;29(1):262–7.
pubmed: 30232723 pmcid: 30232723 doi: 10.1007/s11695-018-3516-1
Shivakumar S, Tantia O, Goyal G, et al. LSG vs MGB-OAGB-3 year follow-up data: a randomised control trial. Obes Surg. 2018;28(9):2820–8.
pubmed: 29679336 pmcid: 29679336 doi: 10.1007/s11695-018-3255-3
Singla V, Aggarwal S, Singh B, et al. Outcomes in super obese patients undergoing one anastomosis gastric bypass or laparoscopic sleeve gastrectomy. Obes Surg. 2019;29(4):1242–7.
pubmed: 30656569 pmcid: 30656569 doi: 10.1007/s11695-018-03673-8
Wang FG, Yu ZP, Yan WM, et al. Comparison of safety and effectiveness between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy: a meta-analysis and systematic review. Medicine (Baltimore). 2017;96(50):e8924.
doi: 10.1097/MD.0000000000008924
Mahawar KK, Borg CM, Kular KS, et al. Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg. 2017;27(9):2222–8.
pubmed: 28361493 pmcid: 28361493 doi: 10.1007/s11695-017-2663-0
Ahuja A, Tantia O, Goyal G, et al. MGB-OAGB: effect of biliopancreatic limb length on nutritional deficiency, weight loss, and comorbidity resolution. Obes Surg. 2018;28(11):3439–45.
pubmed: 30032419 pmcid: 30032419 doi: 10.1007/s11695-018-3405-7
Mahawar KK, Parmar C, Carr WRJ, et al. Impact of biliopancreatic limb length on severe protein-calorie malnutrition requiring revisional surgery after one anastomosis (mini) gastric bypass. J Minim Access Surg. 2018;14(1):37–43.
pubmed: 28695878 pmcid: 28695878 doi: 10.4103/jmas.JMAS_198_16
Betry C, Disse E, Chambrier C, et al. Need for intensive nutrition care after bariatric surgery. JPEN J Parenter Enteral Nutr. 2017;41(2):258–62.
pubmed: 26962058 pmcid: 26962058 doi: 10.1177/0148607116637935

Auteurs

Almino C Ramos (AC)

Gastro-Obeso-Center Institute of Metabolic Optimization, São Paulo, Brazil. ramos.almino@gmail.com.

Jean-Marc Chevallier (JM)

Hopital Européen Georges Pompidou, Paris, France.

Kamal Mahawar (K)

Sunderland Royal Hospital, Sunderland, UK.

Wendy Brown (W)

Department of Surgery Alfred Health, Monash University, Melbourne, Australia.

Lilian Kow (L)

Adelaide Bariatric Centre, Flinders Private Hospital, Bedford Park, Adelaide, South Australia, Australia.

Kevin P White (KP)

Science Right Research Consulting, London, Ontario, Canada.

Scott Shikora (S)

Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH